文献速递皮肤肿瘤

光学UVA生物传感器平台用于防晒剂高通量测试

Optical UVA biosensor platform for high-throughput testing of UV blockers.
PubMed 文献 · J Invest Dermatol · 2026-06-03

本研究开发了一种基于细胞的UVA辐射评估方法(AUVA),利用可光裂解的PhoCl结构域融合四环素阻遏蛋白与VP16激活域,在UVA照射下诱导报告基因发光。该生物传感器可灵敏检测365 nm和395 nm光,诱导倍数高达100倍,为防晒剂UVA防护评估提供高通量、可重复且符合伦理的替代方案。

要点

  • AUVA生物传感器在UVA照射下诱导报告基因表达,最高达100倍。
  • 可灵敏检测365 nm和395 nm波长UVA。
  • 为防晒剂UVA防护因子评估提供高通量体外替代方法。

核心结论

  • AUVA生物传感器平台可实现防晒剂UVA防护的高通量测试,有望替代体内UVA防护因子评估。

研究设计与样本

  • 基于转基因人细胞的细胞学检测方法,表达膜锚定光裂解PhoCl融合四环素阻遏蛋白与VP16激活域,并含核输出信号。

主要发现

  • UVA照射后PhoCl裂解释放四环素阻遏蛋白-VP16,转位至细胞核激活四环素响应报告基因。
  • 该设计可灵敏检测365 nm和395 nm光,诱导倍数高达100倍。

临床怎么用

  • 可用于防晒剂UVA防护的高通量体外筛选与评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UVR is a major public health concern, linked to skin cancer, eye damage, immune suppression, and premature aging. Yet, despite decades of innovation, the gold standard for sunscreen evaluation, sun protection factor and UVA protection factor testing in human volunteers, remains empirical, ethically questionable, and highly variable. In this study, we present an assay for UVA radiation assessment, a high-throughput, cell-based biosensor that luminesces in response to UVA exposure (320-400 nm). Assay for UVA radiation assessment-transgenic human cells express a membrane-anchored, photocleavable PhoCl domain fused to the tetracycline repressor and viral activator VP16, with nuclear export signals that ensure minimal basal activity. Upon UVA illumination, PhoCl cleavage liberates tetracycline repressor-VP16, which translocates to the nucleus and activates a tetracycline-responsive reporter. This molecular design enables sensitive detection of 365 nm and 395 nm light with up to 100-fold induction. By combining precision, reproducibility, and ethical advantages, assay for UVA radiation assessment establishes a powerful platform for the high-throughput testing of UV blockers and offers a transformative alternative to in vivo UVA protection factor assessment.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Unal G, Fussenegger M. Optical UVA biosensor platform for high-throughput testing of UV blockers. J Invest Dermatol. 2026. PMID: 42242496. doi:10.1016/j.jid.2026.05.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。